PL2297357T3 - Przewidywanie odpowiedzi na leczenie przeciwwirusowe - Google Patents
Przewidywanie odpowiedzi na leczenie przeciwwirusoweInfo
- Publication number
- PL2297357T3 PL2297357T3 PL09769355T PL09769355T PL2297357T3 PL 2297357 T3 PL2297357 T3 PL 2297357T3 PL 09769355 T PL09769355 T PL 09769355T PL 09769355 T PL09769355 T PL 09769355T PL 2297357 T3 PL2297357 T3 PL 2297357T3
- Authority
- PL
- Poland
- Prior art keywords
- prediction
- antiviral therapy
- therapy response
- response
- antiviral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08159274 | 2008-06-27 | ||
| PCT/EP2009/058045 WO2009156507A1 (en) | 2008-06-27 | 2009-06-26 | Prediction of antiviral therapy response |
| EP09769355A EP2297357B1 (en) | 2008-06-27 | 2009-06-26 | Prediction of antiviral therapy response |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2297357T3 true PL2297357T3 (pl) | 2013-03-29 |
Family
ID=40163314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09769355T PL2297357T3 (pl) | 2008-06-27 | 2009-06-26 | Przewidywanie odpowiedzi na leczenie przeciwwirusowe |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20110256534A1 (pl) |
| EP (1) | EP2297357B1 (pl) |
| JP (1) | JP2011525799A (pl) |
| KR (1) | KR20110056482A (pl) |
| CN (1) | CN102159725A (pl) |
| AU (1) | AU2009264170A1 (pl) |
| BR (1) | BRPI0914316A2 (pl) |
| CA (1) | CA2728816A1 (pl) |
| ES (1) | ES2398500T3 (pl) |
| MX (1) | MX2010014242A (pl) |
| PL (1) | PL2297357T3 (pl) |
| PT (1) | PT2297357E (pl) |
| RU (1) | RU2011102818A (pl) |
| WO (1) | WO2009156507A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102399852A (zh) * | 2010-09-08 | 2012-04-04 | 上海市公共卫生临床中心 | 用于预测干扰素治疗慢性乙型肝炎疗效的血浆miRNA谱及检测试剂盒 |
| CN102212555A (zh) * | 2011-04-12 | 2011-10-12 | 武汉大学 | 一种可用于表达miR-122载体pSU6-miR-122的构建方法及用途 |
| EP2751286A1 (en) * | 2011-09-04 | 2014-07-09 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Prognostic methods and compositions for predicting interferon treatment eficacy in a subject |
| US9168260B2 (en) * | 2012-02-24 | 2015-10-27 | Baruch S. Blumberg Institute | Benzodiazepine compounds with anti-flavivirus activity |
| TWI454577B (zh) * | 2012-12-19 | 2014-10-01 | Univ Kaohsiung Medical | 預測干擾素療效之方法及套組 |
| PL405648A1 (pl) | 2013-10-15 | 2015-04-27 | Warszawski Uniwersytet Medyczny | Sposób diagnozowania raka watrobowokomórkowego, zastosowanie markera mikroRNA do diagnozowania zmiany chorobowej w obrębie wątroby, oceny stopnia zaawansowania choroby oraz oceny podatności pacjenta i/lub choroby na zaproponowane leczenie oraz zawierający takie markery zestaw diagnostyczny |
| KR20240036134A (ko) | 2014-06-18 | 2024-03-19 | 도레이 카부시키가이샤 | 간암의 검출 키트 또는 디바이스 및 검출 방법 |
| US20170369556A1 (en) * | 2014-12-23 | 2017-12-28 | Ralph A. Tripp | RECOMBINANT CELLS COMPRISING miRNA MIMICS |
| CN106191293A (zh) * | 2016-08-18 | 2016-12-07 | 成都仕康美生物科技有限公司 | 一种基于数字PCR平台的miRNA‑122检测试剂盒及其应用 |
| CN111904973B (zh) * | 2020-07-27 | 2021-12-03 | 中国农业科学院兰州兽医研究所 | ssc-miR-122在制备调节猪繁殖与呼吸综合征病毒复制的药物中的应用 |
| WO2023220584A2 (en) * | 2022-05-09 | 2023-11-16 | The Regents Of The University Ofcolorado A Body Corporate | Regulation of type i ifn signaling by targeting a decoy receptor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| CA2850323A1 (en) | 2004-11-12 | 2006-12-28 | Asuragen, Inc. | Methods and compositions involving mirna and mirna inhibitor molecules |
| AU2006279906B2 (en) | 2005-08-10 | 2012-05-10 | Alnylam Pharmaceuticals, Inc. | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| US8129515B2 (en) | 2006-01-27 | 2012-03-06 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for the use in modulation of microRNAs |
| CA3024953A1 (en) | 2006-04-03 | 2007-10-11 | Roche Innovation Center Copenhagen A/S | Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| WO2009029681A2 (en) * | 2007-08-27 | 2009-03-05 | The Regents Of The University Of California | Micrornas for inhibiting viral replication |
-
2009
- 2009-06-26 CN CN2009801330612A patent/CN102159725A/zh active Pending
- 2009-06-26 BR BRPI0914316A patent/BRPI0914316A2/pt not_active IP Right Cessation
- 2009-06-26 MX MX2010014242A patent/MX2010014242A/es not_active Application Discontinuation
- 2009-06-26 ES ES09769355T patent/ES2398500T3/es active Active
- 2009-06-26 US US12/999,744 patent/US20110256534A1/en not_active Abandoned
- 2009-06-26 CA CA2728816A patent/CA2728816A1/en not_active Abandoned
- 2009-06-26 JP JP2011515400A patent/JP2011525799A/ja active Pending
- 2009-06-26 EP EP09769355A patent/EP2297357B1/en not_active Not-in-force
- 2009-06-26 WO PCT/EP2009/058045 patent/WO2009156507A1/en active Application Filing
- 2009-06-26 KR KR1020117002019A patent/KR20110056482A/ko not_active Application Discontinuation
- 2009-06-26 RU RU2011102818/10A patent/RU2011102818A/ru not_active Application Discontinuation
- 2009-06-26 PT PT97693550T patent/PT2297357E/pt unknown
- 2009-06-26 PL PL09769355T patent/PL2297357T3/pl unknown
- 2009-06-26 AU AU2009264170A patent/AU2009264170A1/en not_active Abandoned
-
2013
- 2013-05-09 US US13/890,482 patent/US20130252233A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2297357A1 (en) | 2011-03-23 |
| RU2011102818A (ru) | 2012-08-10 |
| CA2728816A1 (en) | 2009-12-30 |
| JP2011525799A (ja) | 2011-09-29 |
| PT2297357E (pt) | 2013-01-25 |
| AU2009264170A1 (en) | 2009-12-30 |
| US20110256534A1 (en) | 2011-10-20 |
| BRPI0914316A2 (pt) | 2015-10-13 |
| MX2010014242A (es) | 2011-06-24 |
| US20130252233A1 (en) | 2013-09-26 |
| WO2009156507A1 (en) | 2009-12-30 |
| KR20110056482A (ko) | 2011-05-30 |
| CN102159725A (zh) | 2011-08-17 |
| EP2297357B1 (en) | 2012-10-31 |
| ES2398500T3 (es) | 2013-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2297357E (pt) | Previsão da resposta a uma terapia antiviral | |
| IL207826A0 (en) | Antiviral therapeutic agents | |
| HK1211889A1 (en) | Therapeutic use of diaminophenothiazines | |
| IL209855A0 (en) | Supression of neuroedocrine diseases | |
| EP2320907A4 (en) | THERAPEUTIC COMPOUNDS | |
| HK1148450A1 (en) | Massage mechanism | |
| IL208351A0 (en) | Antiviral therapy | |
| EP2268285A4 (en) | THERAPEUTIC COMPOUNDS | |
| ZA201102604B (en) | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes | |
| GB0806794D0 (en) | Therapeutic compounds | |
| PL2133419T3 (pl) | Zastosowania beta-dipeptydów cyjanoficyny | |
| HK1166371A1 (en) | Prediction of response to platinum-based therapy | |
| HK1247284A1 (zh) | 用於預測受損峰值耗氧氣量的內皮素1原 | |
| GB0804755D0 (en) | Therapeutic compounds | |
| HK1160925A1 (zh) | 組織蛋白酶 的用途 | |
| EP2247531A4 (en) | SILICA REDUCTION | |
| GB0905485D0 (en) | Antiviral therapy | |
| HK1156250A1 (en) | Unit dosage of apadenoson | |
| GB0814895D0 (en) | An improved hydrotherapy unit | |
| TWM370404U (en) | Structure of compound massage set | |
| GB0819857D0 (en) | Antiviral therapy | |
| GB2458212B (en) | Prediction of adverse side effects of drugs | |
| GB0908952D0 (en) | Antiviral therapy | |
| GB0812723D0 (en) | Hydrotherapy spa | |
| GB0813292D0 (en) | Therapy |